HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanping Ding Selected Research

Yanping Ding Research Topics

Disease

24Neoplasms (Cancer)
02/2021 - 08/2009
3Inflammation (Inflammations)
01/2020 - 03/2010
3Triple Negative Breast Neoplasms
01/2017 - 02/2015
3Atherosclerosis
08/2012 - 12/2007
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020 - 12/2019
2Reperfusion Injury
01/2020 - 08/2012
2Neoplasm Metastasis (Metastasis)
11/2019 - 01/2018
2Melanoma (Melanoma, Malignant)
01/2018 - 12/2011
2Breast Neoplasms (Breast Cancer)
02/2016 - 10/2012
2Type 2 Diabetes Mellitus (MODY)
01/2014 - 10/2010
1Multiple Myeloma
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2020
1Retinoblastoma (Glioblastoma, Retinal)
08/2020
1Infarction (Infarctions)
01/2020
1Insulin Resistance
01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2020
1Brain Edema (Cerebral Edema)
01/2020
1Vascular Tissue Neoplasms
01/2019
1AIDS-Related Complex (ARC)
12/2018
1Oral Leukoplakia
09/2017
1Mouth Neoplasms (Oral Cancer)
09/2017
1Hepatitis E
09/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2016
1Fibrosis (Cirrhosis)
02/2016
1Hyperthermia
02/2015
1Hypoxia (Hypoxemia)
10/2012
1Lymphatic Metastasis
10/2012

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2017 - 07/2013
5Peptides (Polypeptides)IBA
11/2019 - 10/2015
4Chimeric Antigen ReceptorsIBA
02/2021 - 12/2019
3Small Interfering RNA (siRNA)IBA
01/2018 - 08/2009
2Proteins (Proteins, Gene)FDA Link
08/2020 - 10/2010
2Biological ProductsIBA
01/2020 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2018
2Caspase 3 (Caspase-3)IBA
09/2017 - 08/2012
2AntibodiesIBA
10/2012 - 10/2010
2CytokinesIBA
10/2010 - 03/2010
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022
1Cyclin DIBA
08/2020
1E2F1 Transcription FactorIBA
08/2020
1Cyclin EIBA
08/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2020
1Superoxide DismutaseIBA
08/2020
1Malondialdehyde (Propanedial)IBA
08/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2020
1Excitatory Amino AcidsIBA
01/2020
1PotassiumIBA
01/2020
1AntioxidantsIBA
01/2020
1PPAR gammaIBA
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
01/2020
1SiliconIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1GhrelinIBA
12/2018
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
07/2018
11- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA
01/2018
12,3-dimethylmaleic anhydrideIBA
01/2018
1LigandsIBA
01/2018
1Tryptophan (L-Tryptophan)FDA Link
01/2018
1Therapeutic UsesIBA
01/2018
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2017
1deoxyuridine triphosphateIBA
09/2017
1SurvivinIBA
09/2017
1PolymersIBA
01/2017
1polydopamineIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Drug CombinationsIBA
01/2017
1VaccinesIBA
09/2016
1GoldIBA
09/2016
1tyrosine receptor (receptor, tyrosine)IBA
04/2016
1Phosphotransferases (Kinase)IBA
04/2016
1CaspasesIBA
04/2016
1Mitogen-Activated Protein KinasesIBA
04/2016
1ErbB Receptors (EGF Receptor)IBA
04/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2016
1human ERBB2 proteinIBA
04/2016
1Liposomes (Liposome)IBA
02/2016
1GemcitabineFDA Link
02/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2016
1CyclodextrinsIBA
02/2016
1pirfenidoneIBA
02/2016
1CollagenIBA
02/2016
1arginyl-glycyl-aspartic acidIBA
02/2016
1PorphyrinsIBA
02/2016
1MicellesIBA
02/2016
1Focal Adhesion Protein-Tyrosine KinasesIBA
10/2015
1Oxygen (Dioxygen)IBA
12/2012
1Vascular Endothelial Growth Factor CIBA
10/2012
1Chemotactic FactorsIBA
10/2012
1Chemokine ReceptorsIBA
10/2012
1ChemokinesIBA
10/2012
1matrigelIBA
09/2012
1NucleolinIBA
09/2012
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
09/2012

Therapy/Procedure

14Therapeutics
10/2020 - 03/2010
3Drug Therapy (Chemotherapy)
07/2018 - 02/2015
2Immunotherapy
02/2021 - 01/2018
2Lasers (Laser)
01/2017 - 02/2015
2Photothermal Therapy
02/2016 - 02/2015
1Intravenous Injections
01/2019